Genetic and clinical predictors of capillary leak syndrome after pediatric allogeneic hematopoietic stem cell transplantation: a single-center cohort study

Capillary leak syndrome (CLS) is a rare but severe complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its risk factors, particularly genetic predisposition in pediatric recipients, remain poorly understood. We aimed to evaluate the clinical and pharmacogenetic determinants of CLS in children undergoing allo-HSCT. We retrospectively analyzed 259 pediatric patients who received allo-HSCT at the Children’s Hospital of Soochow University between June 2017 and January 2022. Clinical data were extracted, and recipient DNA was genotyped for candidate polymorphisms involved in drug metabolism, DNA repair, lipid metabolism, and immune regulation. Cox proportional hazards regression was used to identify risk factors for CLS. Overall survival (OS) was estimated by the Kaplan–Meier method. CLS occurred in 36 of 259 patients (13.9%). Genotype analysis showed that all loci were in Hardy–Weinberg equilibrium (P > 0.05). Patients with CLS had higher rates of peri-engraftment syndrome (Peri-ES), a broader distribution of neutrophil engraftment time, and longer platelet engraftment time. Multivariate analysis identified Peri-ES (HR 2.50, 95% CI 1.21–5.13, p = 0.013), PNPLA3 (444 C > G) mutant genotype (HR 2.16, 95% CI 1.03–4.50, p = 0.040), and DCTD (245-8215G > A) mutant genotype (HR 2.25, 95% CI 1.12–4.51, p = 0.023) as independent risk factors for CLS. The estimated 5-year OS was significantly lower in the CLS group compared with the non-CLS group (69.4% ± 7.7% vs. 90.1% ± 2.0%, log-rank p = 0.00013). This study represents the largest pediatric cohort to date assessing pharmacogenetic associations with CLS. Our findings suggest that both clinical events and genetic background contribute to CLS development after pediatric allo-HSCT. Peri-ES, PNPLA3, and DCTD variants may serve as predictive markers for risk stratification, supporting early monitoring and the design of targeted preventive strategies.

Authors

Institutions

Publication Details

Journal
Annals of Hematology
Published
2026-11-14
DOI
https://doi.org/10.1007/s00277-026-07360-y
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Genetic and clinical predictors of capillary leak syndrome after pediatric allogeneic hematopoietic stem cell transplantation: a single-center cohort study

Qi Ji, 肖佩芳, Yizhen Li, Zhiqi Zhang et al.
Annals of Hematology
Hematopoietic Stem Cell Transplantation
article

Genetic and clinical predictors of capillary leak syndrome after pediatric allogeneic hematopoietic stem cell transplantation: a single-center cohort study

Qi Ji, 肖佩芳, Yizhen Li, Zhiqi Zhang, Zhizhuo Du, Conglian Qiu, Shaoyan Hu, Li Gao, Jing Ling, Hui Zhang, Jun Lu, Jie Li, Shuiyan Wu, Weilin Wang, Yixin Hu, Weiliang Zhang, Yali Fan
article en

Abstract

Capillary leak syndrome (CLS) is a rare but severe complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Its risk factors, particularly genetic predisposition in pediatric recipients, remain poorly understood. We aimed to evaluate the clinical and pharmacogenetic determinants of CLS in children undergoing allo-HSCT. We retrospectively analyzed 259 pediatric patients who received allo-HSCT at the Children’s Hospital of Soochow University between June 2017 and January 2022. Clinical data were extracted, and recipient DNA was genotyped for candidate polymorphisms involved in drug metabolism, DNA repair, lipid metabolism, and immune regulation. Cox proportional hazards regression was used to identify risk factors for CLS. Overall survival (OS) was estimated by the Kaplan–Meier method. CLS occurred in 36 of 259 patients (13.9%). Genotype analysis showed that all loci were in Hardy–Weinberg equilibrium (P > 0.05). Patients with CLS had higher rates of peri-engraftment syndrome (Peri-ES), a broader distribution of neutrophil engraftment time, and longer platelet engraftment time. Multivariate analysis identified Peri-ES (HR 2.50, 95% CI 1.21–5.13, p = 0.013), PNPLA3 (444 C > G) mutant genotype (HR 2.16, 95% CI 1.03–4.50, p = 0.040), and DCTD (245-8215G > A) mutant genotype (HR 2.25, 95% CI 1.12–4.51, p = 0.023) as independent risk factors for CLS. The estimated 5-year OS was significantly lower in the CLS group compared with the non-CLS group (69.4% ± 7.7% vs. 90.1% ± 2.0%, log-rank p = 0.00013). This study represents the largest pediatric cohort to date assessing pharmacogenetic associations with CLS. Our findings suggest that both clinical events and genetic background contribute to CLS development after pediatric allo-HSCT. Peri-ES, PNPLA3, and DCTD variants may serve as predictive markers for risk stratification, supporting early monitoring and the design of targeted preventive strategies.

Annals of Hematology
Soochow University (CN), Children's Hospital of Suzhou University (CN)
Hematopoietic Stem Cell Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon